Breast cancer death rates have dropped for women across the United States over the past two decades. However, they have ...
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer ...
Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct.
Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...
Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...
In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the ...
Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...
Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...
From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 ...
The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...
Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results